Physician profile
Devon Orzano
NPI 1013194927
$1,754.00
in general payments reported to CMS, 2019-2025
12 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.27 · 2022: $310 · 2023: $388 · 2024: $764 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $695.08 | 2022-2025 | Percept PC Brainsense, Stealthstation S8 Platform, Sensight |
| Abbott Laboratories | $446.69 | 2024-2025 | Infinity, Proclaim, Penta |
| Nevro Corp. | $196.45 | 2022-2024 | Senza |
| Insightec,INC | $129.44 | 2023 | Exablate |
| Microtransponder, INC. | $94.98 | 2024 | |
| Integra Lifesciences Corporation | $76.42 | 2022 | |
| Corcept Therapeutics | $37.98 | 2023 | Korlym |
| Astrazeneca Pharmaceuticals LP | $17.27 | 2021 | |
| Amneal Pharmaceuticals LLC | $16.78 | 2023 | Rytary |
| Teva Pharmaceuticals USA, INC. | $14.66 | 2023 | Austedo Xr |
| Eisai INC. | $14.25 | 2023 | |
| Theragen, INC. | $14.00 | 2025 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Orzano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.